Michael Henry is a Psychiatry physician. ClinicalTrials.gov lists 5 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
736 Cambridge St # Qn-3p
Brighton, MA 021352907
Telephone
617-789-2623Registry record last updated 15 Feb 2012.
Clinical trials
- The Effects of Lumateperone on Obesity and Physiologic Aging and Their Association With Antidepressant Response in Bipolar Depression
Sponsor: Massachusetts General Hospital
- The Effects of Vilazodone on Glutamate in the Anterior Cingulate Cortex in Anxious Unipolar Depressives
Sponsor: Massachusetts General Hospital
- Magnetic Resonance Imaging Study of Lisdexamfetamine for Bipolar Depression
Sponsor: Steward St. Elizabeth's Medical Center of Boston, Inc.
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
96.6%Atypical Antipsychotic21.5%Quetiapine Fumarate26%Aripiprazole17%Vraylar14%Olanzapine11%Risperidone7%Caplyta6%Asenapine Maleate6%Lurasidone Hcl6%Paliperidone Er4%Rexulti4%Part D<11 patientsBenzodiazepine17.5%Clonazepam48%Lorazepam25%Alprazolam14%Diazepam13%Part D<11 patients+ 15 more classes in this area
Cardiovascular
2.1%Beta blocker1.5%Propranolol Hcl Er100%Part D<11 patientsStatin0.6%Atorvastatin Calcium100%Part D<11 patientsMetabolism & gastrointestinal
0.7%Biguanide (metformin)0.7%Metformin Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2002–2005 per NIH RePORTER. The latest:
- CBV MAPPING ASSOCIATED WITH CHANGES IN MOOD STATE
Mc Lean Hospital (belmont, Ma)
FY2005$167,911K08MH064175 - CBV MAPPING ASSOCIATED WITH CHANGES IN MOOD STATE
Mc Lean Hospital (belmont, Ma)
FY2004$168,111K08MH064175 - CBV MAPPING ASSOCIATED WITH CHANGES IN MOOD STATE
Mc Lean Hospital (belmont, Ma)
FY2003$168,180K08MH064175
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Philip Scheltens
Inserm
Rafael Tabarés‐Seisdedos
Universitat de València
Nick C. Fox
UK Dementia Research Institute
Perminder S. Sachdev
Department of Health and Aged Care
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”